ARGENTINA (PRWEB) March 22, 2004
A 74 year old engineer with end stage heart failure was treated with stem cell therapy using a very small camera and instruments at the Asociacion Espanola Primera de Socorros Mutuos by a team of multi-national surgeons in Uruguay two weeks ago.
The patient has had severe heart failure for the past 10 years and had minimal improvement with the best medical management. He was continuously short of breath while performing his daily routine.
The stem cell therapy involves taking the patientÂs own bone marrow and purifying it to obtain the type of stem cells which will hopefully give rise to new blood vessels and muscle so the heart can get more oxygen and function better.
ÂThis patient is the first in the world to receive a minimally invasive direct surgical implantation of stems cells into his heart. We have been performing stem cell therapy for heart failure for over one year with excellent early results. Our first patient, who received this therapy in Argentina, had New York Heart Association Class IV heart failure (which is the worst). He was short breath while sitting in place. After his therapy, he currently has no symptoms of heart failure after one year. We continue to follow him and our forty other patients who are part of out multi-national stem trial for heart failure,Â Dr. Amit N. Patel MD MS, University of Pittsburgh & Baylor University Medical Center, USA, who devised the procedure with Dr. Benetti.
ÂStem cell therapy for heart failure has the potential to help a lot of people around the world. If used early, stem cell therapy may decrease the need for heart transplantation.Â Dr Federico Benetti MDÂ President of Benetti Foundation, Argentina.
Heart Failure affects over a million people around the world each year. There are few successful treatment options for these patients.
Early results of surgical stem cell therapy for heart failure will be presented by Dr. Patel on April 25, 2004 at annual meeting of the American Association of Thoracic Surgery
The Benetti Foundation based in Argentina is dedicated to the education and research in the treatment of heart disease around the world.
# # #